Last Update 11 Jul 26
Fair value Increased 2.71%MET: Capital Returns And Flexible Settlement Solutions Will Shape Future Risk Reward Balance
MetLife's analyst price target has been revised from $92.80 to $95.31. Analysts attribute this change to updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E.
What’s in the News for MetLife
- MetLife announced the Non-Qualified Assignment Flex Agreement (NQA-FA), a deferred payment solution that uses a funding agreement instead of an annuity to structure non-physical injury settlements with flexible timing, lump sums, and customized payment schedules.
- The NQA-FA applies to a wide range of non-physical injury cases, including employment litigation, wrongful termination, discrimination, contract disputes, construction defects, property and environmental claims, liability policy buy-outs, punitive damages, and attorney fees, with both individuals and businesses potentially designated as payees.
- MetLife introduced a new liquidity feature for its MetLife Guaranteed Income Program (MGIP) immediate income annuity, offering defined contribution plan participants the option to cancel within the first three years and receive a refund of premiums paid, minus benefits already received, with no cancellation or surrender fees.
- MGIP is structured to convert retirement savings into guaranteed income for life or for a set period, with optional features such as beneficiary protection for remaining value and choices that aim to help payments keep pace with rising costs over time.
- MetLife reported that from January 1, 2026 to March 31, 2026, it repurchased 10,121,118 shares for US$755.49 million, and that under the buyback announced on April 30, 2025, total repurchases reached 21,901,426 shares for US$1,686.95 million, representing 3.32% of shares.
Valuation Changes for MetLife
- Fair Value: revised slightly higher from $92.80 to $95.31 per share, reflecting updated assumptions in the model.
- Discount Rate: adjusted modestly lower from 7.54% to 7.45%, which affects how future cash flows are assessed.
- Revenue Growth: projection refined from 4.45% to 4.53%, indicating a small change in the expected top line trajectory for MetLife.
- Net Profit Margin: updated from 7.55% to 7.66%, a slight shift in the assumed profitability levels.
- Future P/E: terminal P/E assumption moved from 10.06x to 10.14x, a minor change in the valuation multiple applied to MetLife’s future earnings.
Key Takeaways
- Expansion in high-growth international markets and digital innovation drives strong revenue growth and improved margins through efficiency and customer engagement.
- Focus on asset-light, fee-based businesses and early leadership in new platforms supports stable earnings growth and higher returns with less capital intensity.
- Compressed investment yields, underwriting margin volatility, and slow technology adoption threaten profitability, capital stability, and future growth despite improving sales and efficiency measures.
Catalysts
About MetLife- A financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide.
- Strong, sustained premium and sales growth in high-potential international markets (Asia, Latin America, EMEA) positions MetLife to capitalize on growing middle-class wealth and increased insurance penetration, supporting robust long-term revenue and top-line growth.
- Ongoing investment in digital transformation (AI-driven underwriting, process automation, embedded insurance partnerships, and tech-enabled distribution) enables MetLife to reduce acquisition and operating costs, improve customer engagement and retention, and, over time, boost net margins.
- Exposure to major secular shifts-such as the global aging population and the move away from government-provided retirement safety nets-positions MetLife to benefit from rising demand for life insurance, annuities, and private retirement solutions, providing a durable tailwind for premium revenue and fee-based income growth.
- Strategic expansion of asset-light, fee-generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital-intensive earnings growth.
- Early leadership and scale in innovative growth platforms and partnerships (Chariot Re, PineBridge acquisition, digital embedded insurance platforms in LatAm) allow MetLife to capture outsized share in emerging product and distribution opportunities, enhancing future revenue streams and contributing positively to long-term earnings quality.
MetLife Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming MetLife's revenue will grow by 4.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 4.4% today to 7.7% in 3 years time.
- Analysts expect earnings to reach $6.8 billion (and earnings per share of $11.54) by about July 2029, up from $3.4 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $8.1 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 10.2x on those 2029 earnings, down from 17.2x today. This future PE is lower than the current PE for the US Insurance industry at 12.3x.
- Analysts expect the number of shares outstanding to decline by 3.25% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.45%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistent low or volatile interest rates and weaker recurring investment margins, as noted in the call, continue to compress yields on MetLife's fixed-income and general account portfolios, reducing profitability and potentially impacting long-term book value growth.
- Asia's earnings, despite strong sales, were heavily depressed by less favorable underwriting margins and volatile variable investment income, highlighting risks that future AUM or sales growth may not translate into sustained net margin or earnings growth if investment returns don't stabilize.
- Ongoing runoff in the legacy MetLife Holdings block, alongside complexity in executing risk transfer deals (such as long-term care transactions), increases the risk of unfavorable reserve developments and potential net margin or capital volatility if future liabilities or capital charges emerge.
- The company's deliberate pace in digital transformation, though showing improved efficiency, faces the long-term risk of technology-driven disintermediation-should newer insurtechs or direct-to-consumer digital platforms outpace MetLife's ability to modernize distribution, impacting sales growth and cost competitiveness.
- Commercial mortgage loan (CML) losses and continued reserve buildup (e.g., $200M+ increase in CECL reserves for CMLs) underline real asset credit risk; further property downturns could result in additional capital or reserve needs, directly affecting net earnings and statutory capital buffers.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $95.31 for MetLife based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $106.0, and the most bearish reporting a price target of just $75.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $88.6 billion, earnings will come to $6.8 billion, and it would be trading on a PE ratio of 10.2x, assuming you use a discount rate of 7.5%.
- Given the current share price of $91.65, the analyst price target of $95.31 is 3.8% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on MetLife?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.